83 results
8-K
EX-10.2
SKYE
Skye Bioscience Inc
9 Jan 15
Entry into a Material Definitive Agreement
12:00am
this Prospectus is a part is declared effective by the SEC;
through the writing or settlement of options or other hedging transactions, whether … , the selling shareholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales
8-K
EX-10.2
SKYE
Skye Bioscience Inc
12 Oct 18
Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20
6:03am
this Prospectus is a part is declared effective by the SEC;
- through the writing or settlement of options or other hedging transactions, whether through … of this prospectus.
In connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker
8-K
EX-10.2
SKYE
Skye Bioscience Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
or other hedging transactions, whether through an options exchange or otherwise;
broker-dealers may agree with the selling stockholders to sell … into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course
8-K
EX-10.2
SKYE
Skye Bioscience Inc
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
broker-dealers may agree … , the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales
424B3
SKYE
Skye Bioscience Inc
17 May 24
Prospectus supplement
4:27pm
the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
broker-dealers may agree … securityholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the Common
8-K
EX-10.1
zvr7z7 3xy
21 Nov 19
Emerald Bioscience Announces $2.0 Million Registered Direct Offering
5:21pm
8-K
EX-10.1
mgrwf1ky 4oo
5 Aug 20
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
12:00am
424B3
vqru7qj out1
10 Nov 21
Prospectus supplement
8:57am
8-K
EX-10.1
qr69o6tw
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
424B3
359q3asm
7 May 21
Prospectus supplement
8:03am